EDBI

Established in 1991, EDBI is a Singapore-based global investor specializing in high growth technology sectors such as Information & Communication Technology, Emerging Technology, and Healthcare. As a value-creating investor, EDBI supports companies in achieving their ambitious goals by leveraging their extensive network, resources, and expertise. With patient capital, EDBI assists companies looking to expand in Asia and globally through Singapore. Operating as a government organization, EDBI focuses on investments that drive innovation and growth in strategic industries.

Alvin Chew

Managing Partner, Investments

Swee-Yeok Chu

CEO and President

Ang Jen Keng

Deputy Director, Corporate Finance, Corporate Communications and Digital Strategy

Eugene Khoo

Group Director Corporate Finance, Corporate Communications and Digital Strategy

Li Ting Lee

Director, Finance

Lawrence Low

Senior Vice President, Investments and China Head

Basil Lui

Senior Vice President of Investments and Head of Emerging Tech and Value Creation

Paul Ng

Managing Partner, Investments

Jeong Shing Ong

Partner, Investments

Chia Li Yeung

Managing Partner, Investments

166 past transactions

Neon

Private Equity Round in 2021
Starting Their journey as a supplier of electrical appliances in 1956, They have come a long way. Within a few years of their inception, They expanded our business to include the design and instaly ation of shop displays and retail fronts. This is where They began Their journey to transform customer touch points into holistic brand experiences, culminating in the incorporation of Cityneon Displays and Construction.

I-Mab HK

Series C in 2018
I-Mab HK develops drugs to treat diabetes, cancer, and autoimmune diseases. The company develops preclinical compounds, including GX-P2; a long-acting PD-L1 drug for the treatment of inflammatory bowel diseases and GX-G8; a long-acting GLP-2 drug for the treatment of chemotherapy-induced diarrhea and short bowel syndrome. The company was formerly known as Tianzhenshi Biotechnology Company and changed its name to I-Mab HK in March 2017. The company is headquartered in Tianjin, China.

Us2.ai

Series A in 2022
Us2.ai develops software and digital tools for echocardiography using artificial intelligence. It provides online solutions to simplify access of results of echo analysis and heart ultrasound. Us2.ai is based in Singapore.

I-Mab HK

Series C in 2018
I-Mab HK develops drugs to treat diabetes, cancer, and autoimmune diseases. The company develops preclinical compounds, including GX-P2; a long-acting PD-L1 drug for the treatment of inflammatory bowel diseases and GX-G8; a long-acting GLP-2 drug for the treatment of chemotherapy-induced diarrhea and short bowel syndrome. The company was formerly known as Tianzhenshi Biotechnology Company and changed its name to I-Mab HK in March 2017. The company is headquartered in Tianjin, China.

SCI Ecommerce

Venture Round in 2021
Provider of marketing services intended to help in planning and executing digital marketing campaigns. The company offers services that increase brand awareness and conversion rate, which drive sales on various platforms, enabling clients to navigate and manage the complex supply chain and earn more profits.

bolttech

Series A in 2021
Bolttech builds a digital ecosystem that offers a platform to create and provide digital insurance & device protection products & services.

Ember

Series E in 2021
Ember is a design-led temperature control brand whose mission is to revolutionize the way people eat, drink and live. Founded by inventor and serial entrepreneur Clay Alexander, Ember designs and develops patented technology and products that disrupt industries across healthcare, wellness, consumer products and more. From inventing the world’s first temperature control smart mug, to revolutionizing the cold chain for temperature sensitive medicines, Ember is creating a multidisciplinary temperature control platform that brings precision temperature control to your fingertips.

Ivantis

Series B in 2013
Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.

Addex Therapeutics

Series B in 2004
Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally available, small molecule allosteric modulators for central nervous system disorders. Addex allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention – the Addex pipeline was generated from this pioneering allosteric modulator drug discovery platform.

Fluidigm

Venture Round in 2009
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.

GaiaWorks

Series D in 2020
GaiaWorks is a workforce management system developer. GaiaWorks' solution integrates time and attendance, intelligent scheduling, lean working hours, labor optimization to simplify compliance, control labor costs, improve satisfaction and productivity for organizations.

Kadmus Pharmaceuticals

Series A in 2004
Kadmus Pharmaceuticals, Inc., a biopharmaceutical company, commercially exploits endocannabinoid pathways to develop therapeutics. Endocannabinoids are naturally occurring signaling molecules, whose functions include regulating mood, pain, and metabolism. It offers a portfolio of compounds with activity against a range of disorders targeting CNS conditions, metabolic disorders, neuropathic pain, and obesity. The company develops products for various conditions through the inhibition of endocannabinoid degradation and activation of endocannabinoid related pathways and peripheral cannabinoid receptors. It operates in the United States, Canada, and Europe. Kadmus Pharmaceuticals, Inc. was founded in 1998 and is based in Irvine, California.

Modalku

Series C in 2022
Modalku is an online marketplace based in Jakarta, Indonesia for small businesses to acquire loans and for lenders to fund small business loans to earn compelling returns. Its technology-based approach enables borrowers to receive loans for the first time or at lower than market rates, while lenders will earn returns well above that of bank deposits, traditional fixed income products, and life insurance investment-linked products. This marketplace lending model is proven in countries such as USA, UK, China & Singapore.

ImmunoScape

Venture Round in 2021
immunoSCAPE PTE. LTD. focuses on immunotherapy by probing for multiple thymus cell (T cell) specificities, identifying tumor antigen-specific T cells and also by profiling phenotypic and functional T cell. The company, by employing mass cytometry, measures alterations of immune cells, and in particular T cell specificity, for biomarker and target identification. The company is also engaged in vaccine development. immunoSCAPE PTE. LTD. was founded in 2016 and is headquartered in Singapore.

Neuroglee Therapeutics

Series A in 2021
Neuroglee Therapeutics Pte. Ltd. discovers, develops, and commercializes digital therapeutic platform for patients with neurodegenerative diseases. It provides digital therapeutics and monitoring tools that include NG-001, a software for the symptomatic treatment of Alzheimer's disease/MCI, which captures digital biomarkers and learns from user behavior to provide fit-therapy; and investigational prescription digital therapeutic (DTx) that can be used in conjunction with a pharmacotherapy for treating neurodegenerative diseases. The company’s software uses machine-learning algorithms to personalize each patient's therapy by automatically adjusting, or titrating, the therapeutic mobile-based activities based on several novel digital biomarkers tied to cognitive function, mood, and behavior. The company was founded in 2020 and is based in Singapore.

Next Gen Foods

Series A in 2022
Next Gen Foods is a food-tech startup that offers plant-based meats products. We use plants to create a delicious and satisfying meat experience that will make you forget animal meat even exists.

Appier

Series C in 2017
Appier Inc., a technology company that provides artificial intelligence (AI) platforms to help enterprises. Its products include Aideal, which helps businesses to trigger purchase decisions and shortens sales cycles; AIQUA, a proactive customer engagement platform that enables users to engage audience based on their behavior inside and outside application or web environment; AIXON, a data science platform that unifies and enriches existing customer data to help understand audience and run AI models easily to predict future actions; and CrossX advertising, an AI powered advertising solutions that brings optimal campaign performance at scale. The company was founded in 2012 and is based in Taipei, Taiwan. It has additional offices in Taipei, Singapore, Kuala Lumpur, Tokyo, Osaka, Sydney, Ho Chi Minh City, Manila, Hong Kong, Mumbai, New Delhi, Jakarta, Seoul, and Bangkok.

Mirxes

Series C in 2021
MiRXES Pte. Ltd. develops life science research tools and molecular diagnostic tests or research and clinical diagnostic use. It offers RT-qPCR assays, assay panels, spike-in RNA kits, and biomarker discovery solutions. The company was founded in 2014 and is based in Singapore.

Engine Biosciences

Series A in 2021
Engine Biosciences Pte. Ltd. develops a validated platform for drug discovering, developing combination therapeutics, and cellular reprogramming. The company's artificial intelligence and genetic perturbation platform allows researchers and drug developers to uncover the gene interactions and biological networks. It provides test therapies that specifically target genetic interactions, and make analyses and predictions for precision medicine applications. The platform provides drug discovery, such as target discovery, drug repositioning, repurposing, pathway, and massive online analysis (MoA) analysis. It caters to the American fortune 500 companies and research institutions. The company was founded in 2014 and is based in Singapore.

Nature’s Fynd

Series C in 2021
Nature’s Fynd is a food company producing a protein from a microbe discovered in the geothermal springs. The company's mission is to create foods that both nourish people and the planet. Its revolutionary fermentation technology grows protein using a fraction of the land and water resources required by traditional agriculture. Nature’s Fynd was founded in 2012 and is headquartered in Chicago, Illinois.

Funding Societies

Series C in 2022
Funding Societies is an online platform that connects investors with small businesses that need funds, solving the financial inclusion issue by making credit-worthy SMEs bankable. They operate in South East Asia and have won a lot of accolades, including the Global Excellence Award from ITU Telecom, a specialized agency of the United Nations for ICT. They are the first P2P platform that got operating licenses from the regulators in Singapore, Indonesia, and Malaysia. In 5 years, it has helped finance over 3.3 million business loans with over S$1.8 billion in funding.

Nuevocor

Series A in 2021
Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.

Esco Lifesciences

Series A in 2021
Esco Lifesciences Group provides enabling technologies, products, and services for the life sciences and healthcare industries, supporting academic research and scientific discoveries, clinical practice, as well as biopharmaceutical R&D and manufacturing.

Declara

Series A in 2014
Declara, Inc. provides an intelligent social learning platform that connects people to content. Its platform features include social collaboration, intuitive search, content creation, intelligent chat, live mentoring, assessment, and progress tracking. The company provides analytics on how people learn, what content they use/generate, and which peers and mentors help them for customers to own and improve their learning, as well as content providers to refine their products and organizational leaders. It serves governments, companies, educational institutions, and research organizations. The company was founded in 2012 and is based in Palo Alto, California. As of April 11, 2019, Declara, Inc. operates as a subsidiary of Futuryng Inc.

Hummingbird Bioscience

Series C in 2021
Hummingbird Bioscience uses systems biology to develop insights into disease biology and applies computationally guided platforms to discover and engineer breakthrough biotherapeutics. The company is pursuing a broad pipeline of first drug candidates across multiple challenging targets with strong biological validation and disease association, including lead assets: HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, for the treatment of cancer. Hummingbird has established strategic collaborations with Cancer Research UK and Amgen, and has been awarded a product development grant from the Cancer Prevention and Research Institute of Texas.

Mblox

Venture Round in 2011
Founded in 1999, Mblox are the original SMS company. With over 100 direct carrier relationships and a global reputation for expertise in mobile messaging, they are trusted by more companies to carry their mission-critical traffic than any other service. Their cloud based mobile messaging platform processes 7 billion mobile messages a year on behalf of more than 4,000 customers. They provide services to fit any size business, from the small start-up to the largest multinational organisation. Every customer has access to 24/7 email support as standard, provided by an in-house team of experts. In addition they offer a variety of support packages to meet your business needs.

bolttech

Series A in 2021
Bolttech builds a digital ecosystem that offers a platform to create and provide digital insurance & device protection products & services.

M-DAQ

Venture Round in 2019
M-DAQ Pte Ltd (formerly known as Summit Investment Pte Ltd) was founded by a group of veterans from the FX and Securities Industries with experience averaging 15 years amongst the key members. M-DAQ is an innovative and unique solution, providing a platform to price and trade any exchange-traded products in more than one currency by blending ‘executable’ FX rates into equities and futures products. M-DAQ is the IP owner and holds the key relationships with the National Exchanges and the Global FX Banks. M-DAQ handles the entire consultancy work for each Exchange to be enabled on M-DAQ Solution, and provides the Exchange and the FX Consortium Banks with a license to use the M-DAQ solution. In addition, the partner Exchange will receive a revenue share of the net FX margins. The Exchange partners continues to operate the new cross-currency platform under existing in-country regulatory framework.

MetricStream

Venture Round in 2017
MetricStream software provides solutions for quality management, regulatory compliance, risk management, and corporate governance. MetricStream enterprise solutions are used by leading corporations in diverse industries such as pharmaceutical, medical device, high tech manufacturing, energy, financial services, healthcare, manufacturing, food and beverages and automotive to manage quality processes, regulatory and industry-mandated compliance and corporate governance initiatives. MetricStream's product portfolio comprises of a suite of applications based on the patent-pending Enterprise Compliance Platform (ECP). The applications are designed to manage compliance with quality standards, industry regulations, risk programs and corporate policies. In addition, MetricStream's ComplianceOnline.com portal is used by compliance professionals to improve their work productivity and for professional growth. MetricStream, along with its network of partners, provides hosting, implementation, post-sales support, and validation services for its solutions to ensure that customers realize the maximum value from their investments.

Rigetti Computing

Series C in 2020
Rigetti & Co, Inc., an integrated systems company, designs and manufactures quantum computers and the superconducting quantum processors that power them. It offers Quantum, a cloud services platform that enables its machines to be integrated into any public, private, and hybrid cloud environments. The company also provides Forest, a cloud platform to support programs that use a quantum processor and enables programmers to write quantum applications. Rigetti & Co, Inc. was incorporated in 2013 and is based in Berkeley, California with an additional office in Fremont, California.

Moka

Series B in 2018
Moka, a Jakarta-based startup that focusses on building mobile point-of-sale (mPOS) for small and medium businesses. Moka charges its users a monthly subscription fee, depending on the number of stores they have. Transaction data is stored in the cloud which means business owners can access real-time sales data anytime, anywhere. The company was founded in 2014.

vArmour

Venture Round in 2021
vArmour is a leader in data defined perimeter security. Where the world of mobile, virtualization and cloud has moved beyond the traditional perimeter, threats are more sophisticated and CIO’s require greater visibility and control of their data. Based in Mountain View, California, vArmour is founded by security and technology experts from Juniper, Netscreen, RSA and Silvertail. Find out more at www.varmour.com
Screening Eagle Technologies AG develops a cloud-based technology platform that connects sensors, software, and data for intelligent inspection of assets and infrastructure. It offers infrastructure and asset inspection software solutions, such as project management and workflow, and post-processing and analysis; and industrial surface testing for sensors, including concrete, road, geomatics, flaw detection and hardness, metal, castings and automotive, and gloss/paper/coating/film. The company was incorporated in 2019 and is based in Schwerzenbach, Switzerland.

S*Bio

Venture Round in 2008
S*BIO Pte, Ltd., a biotech company, focuses on the discovery and clinical development of novel targeted small drugs for the treatment of cancer. It serves the biotechnology industry in Singapore. The company was founded in 2000 and is based in Singapore, Singapore. S*BIO Pte, Ltd. operates as a subsidiary of Chiron Corporation Limited.

Greenwave Systems

Series C in 2016
Greenwave Systems is a software and services company that leverages Internet of Things technologies to help clients deploy managed services. The company’s product portfolio includes Greenwave360°, an end-to-end software and services solution that speeds time to market, drives down operating expenses, and enhances service levels and customer loyalty. It also provides data and analytics, reference applications, and more. Greenwave Systems was founded in 2008 and is based in Irvine, California.

goBalto

Series C in 2015
GoBalto is a software platform that develops cloud-based solutions for drug trial sponsors and clinical research organizations. Its products offer drug trial sponsors and clinical research organizations the fastest, easiest possible way to start clinical studies on the web. The company was founded in 2008 and headquartered in San Francisco, California.

Aetion

Series B in 2020
Aetion, Inc. develops a science and analytics platform to assess real-world evidence (RWE) from a range of sources. The company offers Aetion Evidence Platform, a platform that generates RWE needed by healthcare decision makers to engage in value-based care. Its solution allows payers, providers, medical device makers, biopharma customers, and academic institutions to analyze data from various clinical and financial interactions in healthcare, including claims, electronic health records, registries, and clinical trials. The company’s platform is also used in database analytics and comparative effectiveness courses taken by epidemiologists, outcomes researchers, health economists, and biostatisticians. It serves customers worldwide. Aetion, Inc. has a strategic collaboration with McKesson. The company was founded in 2012 and is based in New York, New York.

Microbia

Series D in 2004
Microbia an industrial biotechnology company, engages in the development, production, and commercialization of specialty ingredients and biomaterials utilizing fermentation technology. Its products include carotenoids, specialty ingredients, biopolymers, and other biomaterials. The company has a strategic alliance with Tate & Lyle Investments, Ltd. to develop and commercialize fermentation-derived renewable ingredients.

Inviragen

Series A in 2009
Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases worldwide. Inviragen's lead product is a vaccine to protect against dengue fever, a disease that threatens 2.5 billion people across the globe. Inviragen is also developing a vaccine to protect against West Nile for the North American market, a nasal combination vaccine to protect against both plague and smallpox for biodefense, and a unique vaccine to protect against avian influenza for global markets.

SWAT Mobility

Series A in 2019
SWAT Mobility’s vehicle-routing technology helps companies, transport operators and government agencies around the world solve complex transportation challenges. We are the first in Asia to run high-capacity vehicle pooling services that is both on-demand and dynamically-routed. We also have proven results in helping our clients reduce transportation costs, improve city connectivity and reduce traffic congestion woes. Our technology tops the industry Li & Lim's benchmark, and with our cutting-edge smart mobility optimisation engine, we are future-ready for the world of autonomous vehicles.

Vivotech

Series C in 2011
Sequent Software, Inc. acquired ViVOtech’s Software Division in October 2012. ViVOtech, Inc. provides contactless/near field communications (NFC) payment software, NFC smart posters, and over the air card (OTA) provisioning, promotion, and transaction management infrastructure software. Its products include contactless payment systems; ViVOnfc, an OTA infrastructure software for NFC mobile payments and promotions; and ViVOplatform, which provides retailers with the software platform for promotional and loyalty applications. The company also provides merchant, ISO and acquirer, issuing bank, wireless operator, and consumer value proposition solutions. Its products are used in various applications in movie theaters, fast food restaurants, casual dining establishments, convenience stores, gas stations, drug stores, grocery stores, buses, taxicabs, and vending machine locations, as well as by retailers. The company was founded in 2001.

Crisp Mobile

Series C in 2011
A pioneer, innovator and leader in mobile ad technology for more than a decade, Crisp's mission is to help brands activate customers to point-of-purchase experiences through mobile devices. Crisp provides the first end-to-end mobile customer activation platform, Crisp MoCA, that delivers a fully turnkey solution to dominate today and tomorrow's primary point of purchase. Crisp's mature, vertically integrated ad technology and industry-leading product, engineering and operations teams have made it the platform provider of choice for leading CPG's and retailers. Crisp is a privately held company headquartered in New York with offices in Singapore.

Mblox

Venture Round in 2011
Founded in 1999, Mblox are the original SMS company. With over 100 direct carrier relationships and a global reputation for expertise in mobile messaging, they are trusted by more companies to carry their mission-critical traffic than any other service. Their cloud based mobile messaging platform processes 7 billion mobile messages a year on behalf of more than 4,000 customers. They provide services to fit any size business, from the small start-up to the largest multinational organisation. Every customer has access to 24/7 email support as standard, provided by an in-house team of experts. In addition they offer a variety of support packages to meet your business needs.

Magic Leap

Series D in 2017
Magic Leap is a proprietary wearable technology that enables users to interact with digital devices in a completely visually cinematic way. Magic Leap is an Augmented Reality US-based startup that is innovating in the AR space to create new hardware and software that will give its users a never-before-seen AR experience and redefine how we access screens and visualize data. The headset combines a user's inherent visual ability with mobile computing – giving visual output equivalent to real-world experience but powered by mobile tech. Using their Dynamic Digitized Lightfield Signal, they generate images indistinguishable from real objects and place those images seamlessly into the real world.

Artisan Pharma

Series A in 2006
Artisan Pharma, Inc., a biopharmaceutical company, provides critical-care and hospital-based therapeutics to patients, treating physicians, and payors in the United States and internationally. It offers ART-123, a novel, recombinant, and soluble thrombomodulin for the treatment of disseminated intravascular coagulation in sepsis. The company offers its products in Japan, China, Taiwan, and Korea. It has a strategic manufacturing alliance with A-Bio Pharma Pte Ltd. Artisan Pharma, Inc. was formerly known as Artisan Therapeutics, Inc. and changed its name to Artisan Pharma, Inc. in September 2006. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Druva

Series E in 2016
Druva™ delivers data protection and management for the cloud era. Druva Cloud Platform is built on AWS and offered as-a-Service; delivering globally accessible, infinitely scalable and completely autonomous enterprise data resiliency. Customers drive down costs by up to 50 percent by freeing themselves from the burden of unnecessary hardware, capacity planning, and software management. Druva’s patented cloud architecture transforms backup data into an asset, making it more open and accessible so customers can streamline governance, improve cyber resiliency, and gain critical insights to uncover opportunities and expedite decision making.

Puppet

Series F in 2018
Puppet makes infrastructure actionable, scalable and intelligent. From the data center to the cloud, Puppet helps enterprises modernize and manage their infrastructure to deliver innovation and efficiency through continuous automation. More than 40,000 organizations — including more than 80 percent of the Global 5000 — have benefited from Puppet’s open source and commercial solutions to ensure business continuity, optimize costs, boost compliance and ensure security - all while accelerating the adoption of DevOps practices and delivery of self-service.

ShopBack

Series B in 2020
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

MerLion Pharma

Series C in 2010
MerLion Pharmaceuticals GmbH a pharmaceutical company, develops antibacterial drugs and biological products. The company offers finafloxacin, a fluoroquinolone antibiotic for the treatment of infection. The company was founded in 2008 and is based in Berlin, Germany. As of August 21, 2006, MerLion Pharmaceuticals GmbH operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.
Transcelestial is developing the fastest, long-distance, point-to-point wireless communication network possible. It will be delivered as a space data network for terrestrial and satellite applications, which will use lasers to transfer data at up to 1000x faster than what is currently available. The network will be difficult to jam and will not need any spectrum pre-allocation or regulation.

Ambiq Micro

Series E in 2018
Ambiq Micro is an early-stage fabless semiconductor company that is developing ultra-low-power mixed-signal solutions for a new generation of wireless electronics. Ambiq Micro was founded in 2010 on the simple yet powerful notion that extremely low power semiconductors are the key to the future of electronics. Through the use of their pioneering ultra-low-power technology, they help innovative companies around the world develop differentiated solutions that reduce or eliminate the need for batteries, lower overall system power, and maximize industrial design flexibility.

FORMA Therapeutics

Series B in 2009
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing FT-2102, an oral selective small molecule investigational agent that is designed to bind to and inhibit mutated IDH1 enzymes, which is being evaluated in a Phase 2 trial for relapsed/refractory AML, as well as an exploratory Phase 1 trial for glioma; and FT-4101 and FT-8225, which are selective fatty acid synthase inhibitors. The company was founded in 2007 and is headquartered in Watertown, Massachusetts.

Zilingo

Series D in 2019
Zilingo was founded in 2015 by Ankiti Bose and Dhruv Kapoor with a vision to use technology to put fair and efficient business within everyone’s reach. Up until now, the fashion industry has favored a select few - if you had social, human and financial capital, you could get anything done. But we believe the future of fashion belongs to everyone. By using smart, technology-led solutions to bridge the gap between creators and producers, we’re re-imagining the fashion industry to make it accessible, connected and transparent for all. Find out more on business.zilingo.com.

Joby Aviation

Series B in 2018
Joby Aviation develops a new generation of electric personal aircraft created to revolutionize personal mobility. Its strength is in composite airframe design and fabrication, aerodynamic analysis, high-performance electric motor development, and cutting-edge battery pack design, enabling clients to create a paradigm shift in transportation with safe, quiet, fast, and affordable electric vertical takeoff.

Vobile

Series B in 2007
Vobile is the worldwide leader in video and audio content protection, measurement, and monetization services. Its patented core VDNA technologies enable fully automated identification, tracking, and management of any video and audio content with high accuracy and scalability. Vobile operates the VDNA Database (VDDB), which is the most comprehensive database of authorized video fingerprints, metadata, and business rules from major movie studios, television networks, and record labels. Founded in 2005, the company is headquartered in Santa Clara, California, with additional offices in the United States, Japan, and Hong Kong.

Seismic

Series F in 2020
Seismic’s leading sales enableSeismic is the leading global sales and marketing enablement solution, improving close rates, and delivering larger deals for sales while increasing marketing’s impact on the bottom line. Large enterprises use Seismic to increase sales productivity through the automatic distribution of relevant information and personalized content to reps for any buyer interaction. Powerful content controls and visibility into usage ensures brand integrity and reduces risk. Seismic’s machine learning and analytics capabilities continuously improve the entire enablement process for large enterprises, increasing the ROI of sales content and tying it directly to revenue. Headquartered in San Diego and with more than 300 employees across the globe, Seismic is privately held by its executive team and investment firms General Atlantic, JMI Equity, and Jackson Square Ventures.

ElevateBio

Series B in 2020
ElevateBio is a operator of a portfolio of cell and gene therapy companies intended to develop, manufacture and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's most innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases.

Paxata

Series C in 2015
Paxata, Inc. provides adaptive data preparation platform that delivers raw data to ready data for business analysts in the United States and internationally. Its platform enables users to connect, explore, transform, and combine data on their own or work with peers in a shared and transparent environment as they shape data for analytics. The company also provides Data Time Machine, a cloud-based data governance solution that provides security, versioning, and usage visibility; and Adaptive Information Platform, a self-service information platform for Microsoft Azure. Paxata, Inc. has a strategic relationship with Cisco. The company was founded in 2012 and is headquartered in Redwood City, California. As of December 12, 2019, Paxata, Inc. operates as a subsidiary of DataRobot, Inc.

Appcelerator

Series D in 2014
Appcelerator Inc. provides mobile enterprise platform solutions. It offers Appcelerator Platform, which enables cross-platform mobile application development and testing; Arrow, an opinionated framework for building and running mobile APIs; and pre-built push notification services. The company also provides real-time mobile analytics for every native application built on the Appcelerator Platform or directly via native software development kit for iOS and Android. In addition, it offers Titanium, a cross platform native, hybrid, or mobile Web application development platform using JavaScript for iOS, Android, Windows, Blackberry, and HTML5. The company serves Fortune 100 enterprises. Appcelerator Inc. was founded in 2006 and is based in San Jose, California. As of January 14, 2016, Appcelerator Inc. operates as a subsidiary of Axway Inc.

Doctor Anywhere

Series B in 2020
Doctor Anywhere is a Singapore-based telehealth company that provides on demand healthcare solutions to help you lead happier, healthier lives. Their digital platform gives you quick access to health and wellness solutions, wherever you are. Their platform makes healthcare simple, seamless and convenient, and is optimised to help you manage your health in a way that best suits your lifestyle needs. With technology, better health outcomes are more achievable than ever before. They recognize modern-day struggles and are dedicated to improving healthcare services to suit our evolving lifestyle preferences.

Innovalight

Series D in 2010
Founded by Conrad Burke, Innovalight is focused on bringing high efficiency, low-cost solar modules to the marketplace. Enabling this manufacturing paradigm shift is the company's silicon ink, which has been in development since 2005. Historically, silicon has been processed either as a solid or as a gas. Using liquid based processing Innovalight will dramatically improve the cost and efficiency of today's solar modules.

Pico

Series C in 2020
Pico is a leading provider of technology services for the financial markets community. Pico provides a best-in-class portfolio of innovative, transparent, low-latency markets solutions coupled with an agile and expert service delivery model. Instant access to financial markets is provided via PicoNet™, a globally comprehensive network platform instrumented natively with Corvil analytics and telemetry. Clients choose Pico when they want the freedom to move fast and create an operational edge in the fast-paced world of financial markets.

Circles.Life

Venture Round in 2019
Circles.Life is a young, innovative telco, homegrown in Singapore with a mission to re-imagine how mobile services are built and delivered with you in mind. They do this by offering the best no-contract mobile plan, unlimited bonus data and an unparalleled customer experience.

Pear Therapeutics

Series B in 2018
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

Coursera

Series C in 2015
Coursera is an online education company that serves over 20 million registered learners by partnering with 140 of the world’s best universities and education institutions. On Coursera, anyone, anywhere can access over 1,000 online courses and Specializations in dozens of fields in order to achieve meaningful career, educational, and personal enrichment goals throughout their lives. The company was founded in 2012 and is headquartered in Mountain View, California.

MerLion Pharma

Series A in 2002
MerLion Pharmaceuticals GmbH a pharmaceutical company, develops antibacterial drugs and biological products. The company offers finafloxacin, a fluoroquinolone antibiotic for the treatment of infection. The company was founded in 2008 and is based in Berlin, Germany. As of August 21, 2006, MerLion Pharmaceuticals GmbH operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.

Knewton

Series F in 2016
Knewton's mission is to personalize learning for the world. Teachers, schools, and education companies around the world use Knewton to power digital course materials that dynamically adapt to each student’s unique needs. Knewton provides students with tailored recommendations for exactly what to study, teachers with analytics to better support each student, and publishers with content insights to develop more effective digital products. Knewton was founded in 2008 and has offices in New York City, London, Tokyo, Singapore, and Dubai. Knewton has been recognized globally as a “Technology Pioneer” (World Economic Forum in Davos) and several times as one of the top 10 most innovative companies in education (Fast Company).

Livspace

Series D in 2020
Livspace is an interior design startup that offers a platform that connects people to designers, services, and products. The online shopping platform is a destination to find design, decorate, and furnish dream houses so they can undertake renovations like kitchen upgrades or repainting a room. It also provides end-to-end home interior services. In 2016, Livspace launched Canvas, its proprietary design-to-installation platform, a first for the interior design industry that aims to create a unique experience for homeowners and scales the job of interior designers. The décor startup is backed by Goldman Sachs, TPG Growth, Jungle Ventures, Bessemer Ventures, Helion Venture Partners, and Trifecta Capital Advisors. It was founded in 2014 by Anuj Srivastava and Ramakant Sharma.

Amaranth Medical

Series A in 2006
Amaranth Medical, Inc., a medical device company, develops and manufactures bioresorbable scaffolds for vascular and nonvascular applications. It offers FORTITUDE, a bioresorbable coronary scaffold that assists the artery during the remodeling process following an interventional procedure. The company was incorporated in 2005 and is based in Mountain View, California. It has research and manufacturing operations in Singapore; and Silicon Valley, California.

Rotimatic

Series C in 2018
Zimplistic is a kitchen robotics startup founded by husband-wife duo Rishi Israni and Pranoti Nagarkar in 2008. We aspire to help people lead a healthier lifestyle by building intelligent solutions to hard problems. By integrating consumer robotics and Internet of Things (IoT), Zimplistic aims to create enterprising appliances that make healthier eating easier and sustainable. At Zimplistic, our mission is to tackle real-world problems to improve the daily lives of people. This gave rise to Rotimatic, our flagship product. It is the world's first kitchen robot that makes fresh, healthy, homemade rotis with a touch of a button. About Rotimatic - Rotimatic is a roti-making appliance that uses artificial intelligence to make rotis (flatbreads) without the need for human supervision. It is a fully automatic robot that processes all the essential ingredients and produces hot and delicious rotis in under a minute. Rotimatic is a technology marvel, packed with some cutting-edge technology innovated by a talented group of health-conscious people. A complete game changer globally - it is compact, user-friendly, and makes preparing rotis a cakewalk. Since its launch in 2016, Rotimatic has disrupted the kitchen appliances segment by piquing the interest of many. By knocking the hassle out of healthy eating, and helping everyone eat fresh food made at home with handpicked ingredients, we believe that people will eat healthier and live better with Rotimatic. It's become a worldwide kitchen sensation with over 3 million rotis served in thousands of households until June 2017. Rotimatic is available for purchase in Singapore, US, UK, Canada, Australia, and New Zealand. Order now - https://rotimatic.com/order/

Addex Therapeutics

Series C in 2006
Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally available, small molecule allosteric modulators for central nervous system disorders. Addex allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention – the Addex pipeline was generated from this pioneering allosteric modulator drug discovery platform.

Lytro

Series D in 2017
Ground-breaking camera company for consumers

FORMA Therapeutics

Series B in 2009
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing FT-2102, an oral selective small molecule investigational agent that is designed to bind to and inhibit mutated IDH1 enzymes, which is being evaluated in a Phase 2 trial for relapsed/refractory AML, as well as an exploratory Phase 1 trial for glioma; and FT-4101 and FT-8225, which are selective fatty acid synthase inhibitors. The company was founded in 2007 and is headquartered in Watertown, Massachusetts.

Neon

Private Equity Round in 2019
Starting Their journey as a supplier of electrical appliances in 1956, They have come a long way. Within a few years of their inception, They expanded our business to include the design and instaly ation of shop displays and retail fronts. This is where They began Their journey to transform customer touch points into holistic brand experiences, culminating in the incorporation of Cityneon Displays and Construction.

Biofourmis

Series C in 2020
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.

Smaato

Series E in 2014
Smaato’s Digital Advertising Technology Platform gives publishers the controls to deliver seamless, tailored, and engaging experiences for their audiences and advertisers. Advanced targeting capabilities and competitive intelligence help publishers optimize their monetization strategy to create data-driven experiences and reach their full revenue potential. Founded in 2005, Smaato is headquartered in San Francisco, California, with additional offices in Hamburg, New York, Shanghai, Beijing, and Singapore. Learn more at www.smaato.com.

LogRhythm

Venture Round in 2016
LogRhythm is a world leader in NextGen SIEM, empowering thousands of enterprises on six continents to successfully reduce cyber and operational risk by rapidly detecting, responding to and neutralizing damaging cyberthreats. The LogRhythm NextGen SIEM Platform combines advanced security analytics; user and entity behavior analytics (UEBA); network detection and response (NDR); and security orchestration, automation, and response (SOAR) in a single end-to-end solution. LogRhythm’s technology serves as the foundation for the world’s most modern enterprise security operations centers (SOCs), helping customers measurably secure their cloud, physical, and virtual infrastructures for both IT and OT environments. Built for security professionals by security professionals, the LogRhythm NextGen SIEM Platform has won countless customer and industry accolades. LogRhythm was founded in 2003 by Chris Petersen and Phillip Villella to address the unmet and growing need for a comprehensive log and event management solution. Their varied experience with customers gave them insight into how to architect an enterprise-class solution for maximum utility and long-term viability.

Moderna

Series G in 2018
Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies inside patient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology. Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck.

Taulia

Series D in 2014
Taulia is a FinTech startup that provides working capital management and electronic invoicing services for supply chain companies. Its platform helps businesses to turn every invoice into a revenue opportunity using their cash or third-party cash to fund early payments, lower the barriers for e-invoicing participation by accepting all forms of electronic invoices without having to charge suppliers, and empower suppliers to be self-sufficient by giving them access to free self-service and management tool.

Revance Therapeutics

Series D in 2009
Revance Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.

Engine Biosciences

Series A in 2023
Engine Biosciences Pte. Ltd. develops a validated platform for drug discovering, developing combination therapeutics, and cellular reprogramming. The company's artificial intelligence and genetic perturbation platform allows researchers and drug developers to uncover the gene interactions and biological networks. It provides test therapies that specifically target genetic interactions, and make analyses and predictions for precision medicine applications. The platform provides drug discovery, such as target discovery, drug repositioning, repurposing, pathway, and massive online analysis (MoA) analysis. It caters to the American fortune 500 companies and research institutions. The company was founded in 2014 and is based in Singapore.

Moloco

Secondary Market in 2023
Moloco empowers mobile apps to run their own advertising business by providing all of the required components as a cloud service. The company's focus is on delivering quality and scale to our advertisers and publishers has been recognized by the industry. The company is heavily tech-driven with top talents from Google, Amazon, Twitter, and Goldman Sachs. Founded in 2013 with a vision to empower mobile businesses to thrive.

Resolve Biosciences

Series B in 2022
Resolve BioSciences GmbH designs and develops a spatial multiomics analysis platform which helps in the view of single-cell spatial biology. Its platform provides full spatial highest-resolution view of subcellular gene expression activity. Resolve BioSciences GmbH was founded in 2016 and is based in Monheim am Rhein, Germany.

Fazz

Series C in 2022
Fazz Financial is a digital financial services group.

ImmunoScape

Venture Round in 2022
immunoSCAPE PTE. LTD. focuses on immunotherapy by probing for multiple thymus cell (T cell) specificities, identifying tumor antigen-specific T cells and also by profiling phenotypic and functional T cell. The company, by employing mass cytometry, measures alterations of immune cells, and in particular T cell specificity, for biomarker and target identification. The company is also engaged in vaccine development. immunoSCAPE PTE. LTD. was founded in 2016 and is headquartered in Singapore.

Tessa Therapeutics

Venture Round in 2017
Tessa Therapeutics is a provider of therapy designed to focus on T cell therapy for solid tumors. The company's therapy specializes in developing virus specific T-cells and CAR T cells for the treatment of lymphoma, enabling healthcare providers to treat cancer patients and improve their lives.

ShopBack

Series E in 2021
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

AvePoint

Post in 2021
AvePoint is a technology company providing infrastructure management software solutions for Microsoft SharePoint products and technologies. The company also focusing on class big data management, governance, and compliance software solutions for next-generation social collaboration platforms. AvePoint is first to market with a unique solution that centralizes access and control of information assets residing in disparate collaboration and document management systems on-premises and in the cloud. The company's solutions and services aim to bring together business, IT, as well as compliance and risk officers to serve key business objectives such as big data, cloud integration, compliance, enterprise content management, and mobile data access monitoring. AvePoint was founded in 2001 and based out of Jersey City, NJ, serves more than 13,000 organizations in five continents across all industry sectors, with focused practices in the energy and utilities; financial services; healthcare and pharmaceuticals; and public sector industries. AvePoint is a Depth Managed Microsoft Gold Certified Application Development Partner and Gold Certified Collaboration and Content Partner, as well as a US Government GSA provider via strategic partnerships.

TriReme Medical

Series D in 2010
TriReme Medical, Inc. (TMI) is a privately held medical device company based in Pleasanton, California. Founded in 2005, it is dedicated to the development and manufacturing of novel stent technologies for the treatment of coronary artery disease (CAD) at or near bifurcations.

WalkMe

Series F in 2018
designs digital adoption platform that simplifies the user experience. Its digital adoption platform artificial intelligence, machine learning, analytics, and automation to anticipate users' needs and provides help exactly when and where they need it, enabling users to complete their tasks easily.

Tremor Video - Software Platform

Venture Round in 2011
Provides video advertising solutions for advertisers and agencies, and publisher partners in the United States and internationally.

Neuron Mobility

Series B in 2022
Neuron Mobility Pte. Ltd. provides electric scooters and bicycles rental services around Singapore. The company was incorporated in 2016 and is based in Singapore.

RenaMed Biologics

Venture Round in 2006
RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizes physiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island.